This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baquero, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baquero, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 1999, p. 357-359, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Antimicrobial Resistance of 1,113 Streptococcus pneumoniae Isolates from Patients with Respiratory Tract Infections in Spain: Results of a 1-Year (1996-1997) Multicenter Surveillance Study

Fernando Baquero,1 José Angel García-Rodríguez,2 Juan García de Lomas,3 Lorenzo Aguilar,4,* and The Spanish Surveillance Group for Respiratory Pathogensdagger

Microbiology Department, Ramón y Cajal Hospital,1 and Medical Department, SmithKline Beecham Pharmaceuticals,4 Madrid, Microbiology Department, University Hospital, Salamanca,2 and Instituto Valenciano de Microbiología, Valencia,3 Spain

Received 22 May 1998/Returned for modification 7 August 1998/Accepted 12 November 1998


    ABSTRACT
Top
Abstract
Text
References

A nationwide susceptibility surveillance of 1,113 Streptococcus pneumoniae isolates was carried out and found the following percentages of resistance: cefuroxime, 46%; penicillin, 37%; macrolides, 33%; aminopenicillins, 24%; cefotaxime, 13%; and ceftriaxone, 8%. A significant (P < 0.05) seasonality pattern for beta -lactam antibiotics was observed. Resistance to macrolides was higher (P < 0.05) in middle-ear samples. Higher percentages of resistance to cefuroxime and macrolides were observed among penicillin-intermediate and -resistant strains, whereas high frequencies of resistance to aminopenicillins and expanded-spectrum cephalosporins were observed only among penicillin-resistant strains.


    TEXT
Top
Abstract
Text
References

Resistance to penicillin among Streptococcus pneumoniae strains is increasing, with geographical variations (2, 6), making it important to conduct surveillance studies (1). In Spain penicillin resistance increased from 6% (1979) to 44% (1989) (5). Penicillin resistance in S. pneumoniae is often associated with resistance to other antibiotics, such as erythromycin (4, 5).

The aim of this study was to describe the susceptibility of S. pneumoniae in a nationwide antimicrobial surveillance prospective study. All consecutive clinical isolates collected (between May 1996 and April 1997) from patients with community-acquired infections at 14 hospital centers selected on the basis of geographical location were included.

At each center, isolates kept at -70°C were thawed once a month, seeded onto an enriched transport medium, incubated overnight at 35 to 37°C, and shipped to a central laboratory (Instituto Valenciano de Microbiología, Valencia, Spain), where the identities of isolates were confirmed by conventional tests and criteria. Isolates were kept frozen at -70°C in duplicate until antimicrobial susceptibility testing was performed.

Susceptibility testing was performed by using a semiautomated microdilution method in Mueller-Hinton broth supplemented with 3% lysed horse blood according to the guidelines of the National Committee for Clinical Laboratory Standards (NCCLS) (9), with a final inoculum of 5 × 105 CFU/ml, and cultures were incubated 24 h at 35°C under a 5% carbon dioxide atmosphere, with antimicrobials commonly used in empiric therapy in Spain (Table 1). Haemophilus influenzae ATCC 49247, S. pneumoniae ATCC 49619, Staphylococcus aureus ATCC 29213, and Escherichia coli ATCC 25922 were used as control strains. The mechanism of resistance to erythromycin was evaluated by using a double diffusion disk test as described elsewhere (13), with erythromycin (15 µg) and clindamycin (2 µg) disks placed 20 mm apart onto 5% defibrinated horse blood agar and incubated overnight at 35°C under a 5% carbon dioxide atmosphere (10).

Statistical analysis of data was performed by the chi-square test, with the Yates correction when necessary and correction for multiple comparisons (Bonferroni's method).

In vitro susceptibilities are shown in Table 1. Forty percent of isolates were penicillin susceptible, 24% showed intermediate resistance to penicillin, and 36% were penicillin resistant. Extended-spectrum cephalosporins, amoxicillin-clavulanate, and ciprofloxacin exhibited the highest activities (MIC at which 90% of the isolates are inhibited [MIC90] <=  2 µg/ml), whereas macrolides, cefaclor, cefixime, and cefuroxime exhibited the lowest activities (MIC90 >=  8 µg/ml). The prevalence of resistance was around 10% for extended-spectrum cephalosporins, 25% for aminopenicillins, >30% for penicillin and macrolides, and 46% for cefuroxime. Among the oral antibiotics, amoxicillin-clavulanate exhibited the highest intrinsic activity (MIC90 = 2 µg/ml) and the lowest prevalence of resistant strains (25.5%).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   In vitro activities of antimicrobial agentsa against 1,113 S. pneumoniae isolates classified by penicillin susceptibility, and proportions of fully resistant strains

Resistance to both macrolides and cefuroxime was markedly increased in strains showing intermediate resistance to penicillin compared with that in penicillin-susceptible strains (51 versus 6% for macrolides and 40 versus 0% for cefuroxime); this phenomenon was not observed with amoxicillin (with or without clavulanate), cefotaxime, or ceftriaxone. Increases in resistance to aminopenicillins and extended-spectrum cephalosporins were observed only when penicillin-intermediate and -resistant strains were compared. Cefuroxime resistance increased again in the penicillin-resistant strains compared with that in the penicillin-intermediate strains (100 versus 40%, respectively). Penicillin-intermediate and -resistant strains showed the same level of resistance to macrolides (51 to 53%).

Middle-ear isolates exhibited the highest (P < 0.05) percentage of resistance to macrolides (49%) compared with isolates of other origins. Sixty-nine percent of pediatric samples were middle-ear isolates. As described previously (3), pediatric isolates exhibit higher resistance to penicillin compared with isolates from internal medicine patients (50 versus 37%); however, there were no significant differences between medical wards.

Seasonal variations in pneumococcal infections have been documented (7). In this 1-year surveillance study, the overall distribution of isolates by season was 10.3% in the spring of 1996, 13.5% in the summer of 1996, 25.7% in the autumn of 1996, 32.1% in the winter of 1996 to 1997, and 18.6% in the spring of 1997. Statistically significant (P < 0.05) differences were found with respect to seasonal rates, with higher rates of resistance to all beta -lactams in summer and winter. Penicillin resistance rates of 41, 31, 43, and 30% were seen in summer, autumn, winter, and spring, respectively. No seasonality was observed for macrolide resistance rates.

Penicillin resistance among pneumococci has increased in Spain since 1989, from 44% in a previous national survey (5) to 60% in this study when penicillin-intermediate and -resistant strains are included. This increase is attributable to an increase in isolates in the penicillin-resistant category: 36.5% in the present study versus 15.3% in 1989 (5). Furthermore, 58% resistance was found in a study carried out in Madrid on isolates from children with invasive pneumococcal infection between 1989 and 1993; only 14% of the isolates exhibited intermediate resistance (12).

With respect to erythromycin resistance, an increase was identified between 1989 (5) and 1996 to 1997 (10 versus 33.7%, respectively). This increase was due to an increase in the more highly resistant strains (MIC >=  8 µg/ml) from 1990 (8) to 1996 to 1997 (9.4 versus 25.8%, respectively). In this study, the most common erythromycin resistance phenotype found was the constitutive phenotype (98.4%; 369 of 375 isolates); the M phenotype was found in 1.3% (5 strains), and the inducible phenotype was shown only in 1 strain. Interestingly, all five M phenotype isolates came from a single hospital (Insular Hospital, Las Palmas, Spain). Significant differences (P < 0.001) in M phenotype prevalence were found between this hospital (31%; 5 M phenotype isolates among 16 erythromycin-resistant isolates) and others (0%).

It has been suggested that the selective pressure of the local pattern of antibiotic consumption, together with the spread of resistant clones (11), may account for the spread of antibiotic resistance. The consumption of antibiotics has increased in areas where increases in S. pneumoniae resistance have been described (8). In Spain, community antibiotic consumption accounts for 90% of total antibiotic consumption; 50% of this consists of penicillins, 17% consists of macrolides, and 13% consists of oral cephalosporins (2). Antibiotic consumption may be one of the reasons for the seasonal variation in penicillin resistance observed in this study.

Increases in resistance, together with significant local differences in resistance patterns, make local susceptibility surveillance a must in order to establish guidelines for the empiric treatment of respiratory-tract infections.


    ACKNOWLEDGMENTS

This study has been supported by a grant from SmithKline Beecham Pharmaceuticals, Madrid, Spain.


    FOOTNOTES

* Corresponding author. Mailing address: Departamento Médico, SmithKline Beecham Pharmaceuticals, Valle de la Fuenfría, 3, 28034 Madrid, Spain. Phone: 34-91-3345275. Fax: 34-91-3345141. E-mail: lorenzo.aguilar-alfaro{at}sb.com.

dagger The members of the Spanish Surveillance Group for Respiratory Pathogens are T. Jiménez de Anta and F. Marco, Clinic i Provincial Hospital, Barcelona; E. Bouza and E. Cercenado, Gregorio Marañón Hospital, Madrid; R. Gómez-Lus and M. C. Rubio, University Hospital, Zaragoza; M. Gobernado and N. Diosdado, La Fe Hospital, Valencia; I. Trujillano, University Hospital, Salamanca; C. García Riestra and I. Rodríguez, Xeral de Galicia Hospital, Santiago de Compostela; M. de la Rosa and A. Martínez-Brocal, Virgen de las Nieves Hospital, Granada; A. Gutierrez and A. García, La Paz Hospital, Madrid; A. M. Martín Sánchez and F. Cañas, Insular Hospital, Las Palmas; E. Perea and L. Martínez, Virgen Macarena Hospital, Seville; G. Prats and F. Sanchez, Santa Creu i San Pau Hospital, Barcelona; M. Casal and A. Ibarra, Reina Sofia Hospital, Córdoba; R. Cisterna and A. Morla, Basurto Hospital, Bilbao; A. C. Gómez-García and F. J. Blanco-Palenciano, Infanta Cristina Hospital, Badajoz; C. Gimeno and D. Navarro, Instituto Valenciano de Microbiología, Valencia; and A. Torrellas, J. J. Granizo, R. Moreno, and R. Dal-Ré, SmithKline Beecham Pharmaceuticals, Madrid.


    REFERENCES
Top
Abstract
Text
References

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83[Medline].
2. Baquero, F., and The Task Force of the General Direction for Health Planning of the Spanish Ministry of Health. 1996. Antibiotic resistance in Spain: what can be done? Clin. Infect. Dis. 23:819-823[Medline].
3. Block, S. L., C. J. Harrison, J. A. Hedrick, R. D. Tyler, R. A. Smith, E. Keegan, and S. A. Chartrand. 1995. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr. Infect. Dis. J. 14:751-759[Medline].
4. Boswell, T. C. J., D. Frodsham, K. J. Nye, and E. G. Smith. 1996. Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham Public Health Laboratory, 1989-94. J. Infect. 33:17-22[Medline].
5. Fenoll, A., C. M. Burgon, R. Muñoz, D. Vicioso, and J. Casal. 1991. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev. Infect. Dis. 13:56-60[Medline].
6. Goldstein, F. W., J. Liñares, J. Melo Cristino, et al. 1996. Comparison of the intrinsic activity of 9 betalactams against 1,131 strains of Streptococcus pneumoniae isolated in the 11 European countries between 1993 and 1995, abstr. T 148. In Abstracts of the First European Congress of Antimicrobial Chemotherapy 1996.
7. Grandsden, W. R., S. J. Eykyn, and I. Philips. 1985. Pneumococcal bacteraemia: 325 episodes diagnosed at St. Thomas's Hospital. Br. Med. J. 290:505-508.
8. Liñares, J., R. Pallarés, T. Alonso, J. L. Pérez, J. Ayats, F. Gudiol, P. F. Viladrich, and R. Martín. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105[Medline].
9. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Orden, B., E. Pérez-Trallero, M. Montes, and R. Martínez. 1988. Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatr. Infect. Dis. J. 17:470-473.
11. Privitera, G. 1994. Penicillin resistance among Streptococcus pneumoniae in Europe. Diagn. Microbiol. Infect. Dis. 19:157-161[Medline].
12. Ramos, J. T., J. Saavedra, J. Ruíz-Contreras, J. Bravo, F. Sanz, and A. R. Noriega. 1998. Invasive antibiotic-resistant Streptococcus pneumoniae in children in Madrid. Pediatr. Infect. Dis. J. 17:252-255[Medline].
13. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824[Abstract].

Antimicrobial Agents and Chemotherapy, February 1999, p. 357-359, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Garvey, M. I., Piddock, L. J. V. (2008). The Efflux Pump Inhibitor Reserpine Selects Multidrug-Resistant Streptococcus pneumoniae Strains That Overexpress the ABC Transporters PatA and PatB. Antimicrob. Agents Chemother. 52: 1677-1685 [Abstract] [Full Text]  
  • Sevillano, D., Aguilar, L., Alou, L., Gimenez, M.-J., Echevarria, O., Cafini, F., Valero, E., Fenoll, A., Prieto, J. (2006). Effects of antimicrobials on the competitive growth of Streptococcus pneumoniae: a pharmacodynamic in vitro model approach to selection of resistant populations. J Antimicrob Chemother 58: 794-801 [Abstract] [Full Text]  
  • Siquier, B., Sanchez-Alvarez, J., Garcia-Mendez, E., Sabria, M., Santos, J., Pallares, R., Twynholm, M., Dal-Re, R., on behalf of the 620 Clinical Study Group, (2006). Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 57: 536-545 [Abstract] [Full Text]  
  • Nunes, S., Sa-Leao, R., Carrico, J., Alves, C. R., Mato, R., Avo, A. B., Saldanha, J., Almeida, J. S., Sanches, I. S., de Lencastre, H. (2005). Trends in Drug Resistance, Serotypes, and Molecular Types of Streptococcus pneumoniae Colonizing Preschool-Age Children Attending Day Care Centers in Lisbon, Portugal: a Summary of 4 Years of Annual Surveillance. J. Clin. Microbiol. 43: 1285-1293 [Abstract] [Full Text]  
  • Fernandez, A., Cabellos, C., Tubau, F., Maiques, J. M., Domenech, A., Ribes, S., Linares, J., Viladrich, P. F., Gudiol, F. (2005). Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. J Antimicrob Chemother 55: 78-83 [Abstract] [Full Text]  
  • Oteo, J., Lazaro, E., de Abajo, F. J., Baquero, F., Campos, J., Spanish Members of the European Antimicrobial Resi, (2004). Trends in Antimicrobial Resistance in 1,968 Invasive Streptococcus pneumoniae Strains Isolated in Spanish Hospitals (2001 to 2003): Decreasing Penicillin Resistance in Children's Isolates. J. Clin. Microbiol. 42: 5571-5577 [Abstract] [Full Text]  
  • Canton, R., Morosini, M., Enright, M. C., Morrissey, I. (2003). Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J Antimicrob Chemother 52: 944-952 [Abstract] [Full Text]  
  • Reynolds, R., Shackcloth, J., Felmingham, D., MacGowan, A., on behalf of the BSAC Extended Working Party on Re, (2003). Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme. J Antimicrob Chemother 52: 931-943 [Abstract] [Full Text]  
  • Mason, E. O. Jr., Lamberth, L. B., Wald, E. R., Bradley, J. S., Barson, W. J., Kaplan, S. L. (2003). In Vitro Activities of Cethromycin (ABT-773), a New Ketolide, against Streptococcus pneumoniae Strains That Are Not Susceptible to Penicillin or Macrolides. Antimicrob. Agents Chemother. 47: 166-169 [Abstract] [Full Text]  
  • Bogaert, D., Ha, N. T., Sluijter, M., Lemmens, N., de Groot, R., Hermans, P. W. M. (2002). Molecular Epidemiology of Pneumococcal Carriage among Children with Upper Respiratory Tract Infections in Hanoi, Vietnam. J. Clin. Microbiol. 40: 3903-3908 [Abstract] [Full Text]  
  • Perez-Trallero, E., Garcia-Rey, C., Martin-Sanchez, A. M., Aguilar, L., Garcia-de-Lomas, J., Ruiz, J. (2002). Activities of Six Different Quinolones against Clinical Respiratory Isolates of Streptococcus pneumoniae with Reduced Susceptibility to Ciprofloxacin in Spain. Antimicrob. Agents Chemother. 46: 2665-2667 [Abstract] [Full Text]  
  • Casal, J., Aguilar, L., Jado, I., Yuste, J., Gimenez, M. J., Prieto, J., Fenoll, A. (2002). Effects of Specific Antibodies against Streptococcus pneumoniae on Pharmacodynamic Parameters of {beta}-Lactams in a Mouse Sepsis Model. Antimicrob. Agents Chemother. 46: 1340-1344 [Abstract] [Full Text]  
  • Del Grosso, M., Iannelli, F., Messina, C., Santagati, M., Petrosillo, N., Stefani, S., Pozzi, G., Pantosti, A. (2002). Macrolide Efflux Genes mef(A) and mef(E) Are Carried by Different Genetic Elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40: 774-778 [Abstract] [Full Text]  
  • Balcabao, I. P., Alou, L., Aguilar, L., Gomez-Lus, M. L., Gimenez, M. J., Prieto, J. (2001). Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones. J Antimicrob Chemother 48: 907-909 [Abstract] [Full Text]  
  • Perez-Trallero, E., Fernandez-Mazarrasa, C., Garcia-Rey, C., Bouza, E., Aguilar, L., Garcia-de-Lomas, J., Baquero, F., The Spanish Surveillance Group for Respiratory Pat, (2001). Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998-1999) Multicenter Surveillance Study in Spain. Antimicrob. Agents Chemother. 45: 3334-3340 [Abstract] [Full Text]  
  • Alou, L., Ramirez, M., Garcia-Rey, C., Prieto, J., de Lencastre, H. (2001). Streptococcus pneumoniae Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Clonal Diversity and Appearance of Ciprofloxacin-Resistant Epidemic Clones. Antimicrob. Agents Chemother. 45: 2955-2957 [Abstract] [Full Text]  
  • de Neeling, A. J., Overbeek, B. P., Horrevorts, A. M., Ligtvoet, E. E. J., Goettsch, W. G. (2001). Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999. J Antimicrob Chemother 48: 441-444 [Abstract] [Full Text]  
  • Morosini, M.-I., Canton, R., Loza, E., Negri, M.-C., Galan, J.-C., Almaraz, F., Baquero, F. (2001). In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance Mechanisms. Antimicrob. Agents Chemother. 45: 2427-2431 [Abstract] [Full Text]  
  • Bogaert, D., Engelen, M. N., Timmers-Reker, A. J. M., Elzenaar, K. P., Peerbooms, P. G. H., Coutinho, R. A., de Groot, R., Hermans, P. W. M. (2001). Pneumococcal Carriage in Children in The Netherlands: a Molecular Epidemiological Study. J. Clin. Microbiol. 39: 3316-3320 [Abstract] [Full Text]  
  • Hoban, D. J., Wierzbowski, A. K., Nichol, K., Zhanel, G. G. (2001). Macrolide-Resistant Streptococcus pneumoniae in Canada during 1998-1999: Prevalence of mef(A) and erm(B) and Susceptibilities to Ketolides. Antimicrob. Agents Chemother. 45: 2147-2150 [Abstract] [Full Text]  
  • Fitoussi, F., Loukil, C., Gros, I., Clermont, O., Mariani, P., Bonacorsi, S., Le Thomas, I., Deforche, D., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France. Antimicrob. Agents Chemother. 45: 1889-1891 [Abstract] [Full Text]  
  • Garcia-Garrote, F., Cercenado, E., Martin-Pedroviejo, J., Cuevas, O., Bouza, E. (2001). Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens. J Antimicrob Chemother 47: 681-684 [Abstract] [Full Text]  
  • Sahm, D. F., Karlowsky, J. A., Kelly, L. J., Critchley, I. A., Jones, M. E., Thornsberry, C., Mauriz, Y., Kahn, J. (2001). Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis. Antimicrob. Agents Chemother. 45: 1037-1042 [Abstract] [Full Text]  
  • Fitoussi, F., Doit, C., Geslin, P., Brahimi, N., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France. Antimicrob. Agents Chemother. 45: 636-638 [Abstract] [Full Text]  
  • Oteo, J., Alos, J. I., Gomez-Garces, J. L. (2001). Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicentre surveillance study. J Antimicrob Chemother 47: 215-218 [Abstract] [Full Text]  
  • Syrogiannopoulos, G. A., Grivea, I. N., Tait-Kamradt, A., Katopodis, G. D., Beratis, N. G., Sutcliffe, J., Appelbaum, P. C., Davies, T. A. (2001). Identification of an erm(A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniae Isolated in Greece. Antimicrob. Agents Chemother. 45: 342-344 [Abstract] [Full Text]  
  • García-Rey, C., Aguilar, L., Baquero, F., Spanish Surveillance Group for Respiratory Pathoge, (2000). Influences of Different Factors on Prevalence of Ciprofloxacin Resistance in Streptococcus pneumoniae in Spain. Antimicrob. Agents Chemother. 44: 3481-3482 [Full Text]  
  • Bogaert, D., Syrogiannopoulos, G. A., Grivea, I. N., de Groot, R., Beratis, N. G., Hermans, P. W. M. (2000). Molecular Epidemiology of Penicillin-Nonsusceptible Streptococcus pneumoniae among Children in Greece. J. Clin. Microbiol. 38: 4361-4366 [Abstract] [Full Text]  
  • Granizo, J. J., Aguilar, L., Casal, J., Garcia-Rey, C., Dal-Re, R., Baquero, F. (2000). Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and {beta}-lactam consumption in Spain (1979-1997). J Antimicrob Chemother 46: 767-773 [Abstract] [Full Text]  
  • Marco, F., Bouza, E., Garcia-de-Lomas, J., Aguilar, L. (2000). Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. J Antimicrob Chemother 46: 557-564 [Abstract] [Full Text]  
  • Betriu, C., Redondo, M., Palau, M. L., Sánchez, A., Gómez, M., Culebras, E., Boloix, A., Picazo, J. J. (2000). Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci. Antimicrob. Agents Chemother. 44: 1838-1841 [Abstract] [Full Text]  
  • Hsueh, P.-R., Liu, Y.-C., Shyr, J.-M., Wu, T.-L., Yan, J.-J., Wu, J.-J., Leu, H.-S., Chuang, Y.-C., Yeu-Jen Lau, , Luh, K.-T. (2000). Multicenter Surveillance of Antimicrobial Resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 Respiratory Season. Antimicrob. Agents Chemother. 44: 1342-1345 [Abstract] [Full Text]  
  • Heaton, V. J., Goldsmith, C. E., Ambler, J. E., Fisher, L. M. (1999). Activity of Gemifloxacin against Penicillin- and Ciprofloxacin-Resistant Streptococcus pneumoniae Displaying Topoisomerase- and Efflux-Mediated Resistance Mechanisms. Antimicrob. Agents Chemother. 43: 2998-3000 [Abstract] [Full Text]  
  • Oster, P., Zanchi, A., Cresti, S., Lattanzi, M., Montagnani, F., Cellesi, C., Rossolini, G. M. (1999). Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates. Antimicrob. Agents Chemother. 43: 2510-2512 [Abstract] [Full Text]  
  • Gómez-Lus, R., Granizo, J. J., Aguilar, L., Bouza, E., Gutierrez, A., García-de-Lomas, J., Spanish Surveillance Group for Respiratory Pathoge, (1999). Is There an Ecological Relationship between Rates of Antibiotic Resistance of Species of the Genus Streptococcus?. J. Clin. Microbiol. 37: 3384-3386 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baquero, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baquero, F.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»